• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
SNT

SYNTARA LIMITED

52.6% ! 2.7¢
Market Cap $43.94M  !

Syntara Limited is an Australia-based clinical-stage drug development company. The... Syntara Limited is an Australia-based clinical-stage drug development company. The Company is targeting extracellular matrix dysfunction with its amine oxidase chemistry and other technologies to develop novel medicines for blood cancers and conditions linked to inflammation and fibrosis. The Company’s lead candidate SNT-5505 is for the bone marrow cancer myelofibrosis which causes a build-up of scar tissue that leads to loss of red and white blood cells and platelets. The Company is also advancing both oral and topical pan-LOX inhibitors in scar prevention and scar modification programs. Its product candidate, SNT-4728, is an inhibitor to treat sleep disorders and slow progression of neurodegenerative diseases like Parkinson’s by reducing neuroinflammation. The Company’s other drug candidates target fibrotic and inflammatory diseases such as kidney fibrosis, NASH, pulmonary fibrosis and cardiac fibrosis.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
SNT 22:33 68 17K
22:33 Last post  PJCCopper Comments Created with Sketch.  68  Views Created with Sketch.  17K 
SNT 17:01 4 1.3K
17:01 Last post  ma420 Comments Created with Sketch.  4  Views Created with Sketch.  1.3K 
SNT
No Rush to Buy more
11:22 1 578
11:22 Last post  CytokineRelease Comments Created with Sketch.  1  Views Created with Sketch.  578 
SNT
Value of Syntara
3 4 5
08/08/25 270 88K
08/08/25 Last post  dc1234 Comments Created with Sketch.  270  Views Created with Sketch.  88K 
SNT 08/08/25 12 4.0K
08/08/25 Last post  NZ Trader Comments Created with Sketch.  12  Views Created with Sketch.  4.0K 
SNT 08/08/25 0 298
08/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  298 
SNT 04/08/25 0 261
04/08/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  261 
SNT 04/08/25 3 935
04/08/25 Last post  Samyouel Comments Created with Sketch.  3  Views Created with Sketch.  935 

See All Discussions arrow Created with Sketch.

Timeline

FDA guidance webinar
11 Aug 09:51
 
Guidance from FDA on amsulostat clinical progression
11 Aug 09:49
 
Application for quotation of securities - SNT
08 Aug 08:33
 
Reinstatement to Quotation
04 Aug 09:39
 
Proposed issue of securities to the CEO
04 Aug 08:39
 
Notification regarding unquoted securities - SNT
04 Aug 08:37
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
2.7¢
Change
-0.030(52.6%)
Mkt cap ! $43.94M
Open High Low Value Volume
5.4¢ 5.4¢ 2.7¢ $2.754M 90.37M

Buyers (Bids)

No. Vol. Price($)
21 6416796 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.9¢ 624400 4
View Market Depth
Last trade - 16.10pm 11/08/2025 (20 minute delay) ?
Last
2.7¢
  Change
-0.030 ( 51.8 %)
Open High Low Volume
5.0¢ 5.0¢ 2.7¢ 29441392
Last updated 15.59pm 11/08/2025 ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.